Prostate Cancer
Study Findings on Prostate Cancer Are Outlined in Reports from University of Texas
Published in Drug Week, February 11th, 2011
2011 FEB 11 -- "Despite the clinical regression that typifies the initial response of advanced prostate cancer to gonadal testosterone depletion, tumors eventually progress. However, evidence supports the concept that signaling via the androgen receptor (AR) is important in progression to castration-resistant prostate cancer (CRPC)," scientists writing in the Journal of Investigative Medicine report.
"Steroid hormones are synthesized from cholesterol in a series of tightly regulated steps involving the cleavage of carbon-carbon bonds, the introduction of functional groups derived from activated molecular oxygen, and the oxidation and reduction of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2011-02-11)
More Articles from Drug Week
- Coagulation
Data from M. Kreuzer and Colleagues Advance Knowledge in Coagulation - Neurochemistry
Data from Wayne State University, Department of Pharmacology Provide New Insights into Neurochemistry - Central Nervous System
Data on Central Nervous System Detailed by J.L. Yang and Co-Authors - Molecular Biology
Data on Molecular Biology Published by Researchers at University of North Carolina - Peptide Hormones
Data on Peptide Hormones Described by Researchers at University of Basrah - Biological and Pharmaceutical Research
Findings from Kobe Gakuin University, Department of Clinical Pharmacy Broaden Understanding of Biological and Pharmaceutical Research - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
